Press Releases May 19, 2026 04:05 PM

Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

Resmed to Present at the 46th Annual William Blair Growth Stock Conference

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
RMD

Resmed announced that its chairman and CEO, Mick Farrell, and CFO, Aaron Bloomer, will participate in the 46th Annual William Blair Growth Stock Conference on June 2, 2026, including a webcast presentation accessible to investors and the public.

Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
RMD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Resmed leadership will present company updates and growth strategies at a major growth stock conference.
  • The presentation will be available live and via webcast replay, facilitating broad investor access.
  • Resmed focuses on AI-powered digital health solutions and cloud-connected devices to improve home healthcare and sleep health globally.

SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 46th Annual William Blair Growth Stock Conference in Chicago, IL on Tuesday, June 2, 2026. Resmed’s webcast presentation will begin at approximately 4:40 p.m. (Central Time).

More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.

About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

For investors
+1 858.221.3304
[email protected]
For media
+1 619.510.1281
[email protected]



Risks

  • Market reception to the company's growth strategy and presentation is uncertain, possibly impacting investor sentiment.
  • Dependence on the adoption and regulatory approval of AI-driven health technologies could pose risks.
  • Global healthcare market dynamics and competition may affect Resmed's expansion and profitability.

More from Press Releases

UK businesses drastically overestimate their AI progress Jul 8, 2026 FTI Consulting Expands UK TMT Leadership to Help Companies Navigate Regulatory Scrutiny, Transformation and Stakeholder Pressure Jul 8, 2026 FuelCell Energy Announces Upsize and Pricing of Offering of Common Stock Jul 7, 2026 Concorde International Group Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency Jul 7, 2026 Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jul 7, 2026